Shujie Zhai

1PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 07, 2026
Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial.

Lu Chen, Shujie Zhai, Yayue Liu

Pageof 1

Frequent Collaborators

1 joint publications

Yongmei Li

1 joint publications

Jihui Hao

1 joint publications

Tianqiang Song